Alpha Crest Capital Management LLC Novo Cure LTD Transaction History

Alpha Crest Capital Management LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $1.14 Million - $1.5 Million	-16,762 Reduced 63.3%	9,718 $738,000
Q2 2022 Aug 11, 2022	BUY	$56.6 - $89.9 $1.1 Million - $1.75 Million	19,485 Added 278.56%	26,480 $1.84 Million
Q1 2022 May 12, 2022	SELL	$60.15 - $84.52 $1.14 Million - $1.6 Million	-18,907 Reduced 72.99%	6,995 $580,000
Q4 2021 Feb 09, 2022	BUY	$75.08 - $121.99 $1.15 Million - $1.87 Million	15,302 Added 144.36%	25,902 $1.95 Million
Q3 2021 Nov 10, 2021	BUY	$116.17 - $194.55 $846,646 - $1.42 Million	7,288 Added 220.05%	10,600 $1.23 Million
Q2 2021 Aug 12, 2021	SELL	$130.4 - $225.58 $583,800 - $1.01 Million	-4,477 Reduced 57.48%	3,312 $735,000
Q1 2021 May 13, 2021	BUY	$124.11 - $190.17 $966,692 - $1.48 Million	7,789 New	7,789 $1.03 Million
Q4 2020 Feb 12, 2021	SELL	$112.16 - $174.14 $257,968 - $400,521	-2,300 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$58.05 - $111.31 $174,150 - $333,930	-3,000 Reduced 56.6%	2,300 $256,000
Q2 2020 Aug 12, 2020	SELL	$57.2 - $74.41 $286,000 - $372,050	-5,000 Reduced 48.54%	5,300 $314,000
Q1 2020 May 13, 2020	BUY	$57.05 - $95.75 $336,595 - $564,925	5,900 Added 134.09%	10,300 $694,000
Q4 2019 Feb 12, 2020	SELL	$68.3 - $93.8 $881,070 - $1.21 Million	-12,900 Reduced 74.57%	4,400 $371,000
Q3 2019 Nov 12, 2019	BUY	$61.86 - $97.8 $377,346 - $596,580	6,100 Added 54.46%	17,300 $1.29 Million
Q2 2019 Aug 12, 2019	BUY	$42.22 - $63.23 $472,864 - $708,176	11,200 New	11,200 $708,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.77B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.